1. Introduction {#sec1}
===============

Ventricular (or cardiac) remodeling is commonly defined as a physiological or pathological process that can occur under various conditions of pressure/volume overload. A common feature of ventricular remodeling is hypertrophy of the cardiomyocytes. The type of cardiac workload determines the pattern of ventricular hypertrophy: volume overload induces eccentric, while pressure overload induces concentric remodeling. Under various pathological conditions, compensatory concentric hypertrophy can lead to eccentric hypertrophy, dilatory ventricular remodelling, and heart failure (reviewed in \[[@B1], [@B2]\]). The molecular signature of concentric versus eccentric hypertrophy, although poorly defined as yet, is nevertheless of critical relevance in cardiac basic and clinical research \[[@B3]--[@B8]\].

The early neonatal heart is a conventional model for the study of distinct patterns of ventricular hypertrophy (i.e., concentric versus eccentric). At birth, cardiomyocytes begin to enlarge in response to the demands of physiological workload, as opposed to processes driven predominantly by developmental mechanisms. Particularly, the left ventricle (LV) is exposed to a higher-pressure overload in comparison to the right ventricle (RV), which is exposed to a relatively higher-volume overload. As a result, the LV undergoes rapid concentric hypertrophy, while the RV undergoes eccentric hypertrophy associated with dilatory RV-chamber remodeling. Our previous data revealed differences in the expression of cardiac ankyrin repeat domain 1 factor (ANKRD1/CARP) between the LV and RV before the appearance of morphologically identifiable signs of LV-concentric or RV-eccentric hypertrophy in newborn piglets \[[@B9]\]. Other research reported certain LV/RV-specific metabolic differences in normal and ischemic newborn piglet heart \[[@B7]\]. We interpreted these results as reflecting a certain type of molecular predisposition of newborn ventricular myocardium to LV-concentric and RV-eccentric remodeling during postnatal development.

In the present study, we focused on large-scale transcriptomic analysis to compare differences in gene expression levels in the LV versus RV in newborn piglets. Given that commercially available DNA microarray platforms suitable for performing transcriptional profiling in pig are still poorly developed, we conducted comparative LV versus RV gene expression profiling in newborn piglets using mRNA differential display (DDRT-PCR). In addition, unlike microarray-based platforms, DDRT-PCR can be used to detect expression changes in both known and novel transcripts including alternate splice variants \[[@B10]\]. This approach allowed us (1) to perform an unbiased assessment of genes which expression is predominantly associated with piglet LV or RV myocardium and (2) to distil a large body of expression data into a discrete set of candidate genes for which regulation was not previously recognized as being chamber-dependent. Further studies on these differentially regulated genes will likely lead to the identification of additional novel gene families and pathways involved in the chamber-dependent response of ventricular myocardium to a variety of physiological and pathological stimuli.

2. Materials and Methods {#sec2}
========================

2.1. Animals and Tissue Sampling {#sec2.1}
--------------------------------

Animals were treated and cared for in accordance with the European commission directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes, and all animal protocols were approved by the ethical research committee of Galicia (Spain). Newborn (10--12 hours after birth) Large White piglets were obtained from a local commercial breeder (La Coruña, Galicia) and maintained in an automatic nursery system (Nütinger System). The newborn and 20-day-old animals were anaesthetized, the thoracic cavity was opened through a median sternotomy, and the entire heart was rapidly removed, weighed, and photographed while still beating. Then the isolated heart was placed on an ice-cold petri dish, partially sectioned at the midpoint of the LV length and photographs of the open ventricular chambers were taken ([Figure 1](#fig1){ref-type="fig"}). Immediately after this step, the LV and RV free walls were dissected, flash frozen in liquid nitrogen, and stored at −80°C until study.

2.2. RNA Isolation {#sec2.2}
------------------

Deep-frozen tissue samples (100--150 mg), encompassing the full thickness of the free wall of the LV and RV ventricle, were directly disrupted in RLT buffer (Qiagen) using a high-speed rotor-stator homogenizer (Ultra-Turrax T8, Germany), digested with Proteinase K (Qiagen), loaded onto a RNeasy Midi column (Qiagen), subjected to on-column digestion of DNA with RNase-free DNase (Qiagen) and the analysis proceeded in accordance with the manufacturer\'s recommendations. Resulting RNA preparations were ethanol-precipitated, resolved in RNase-free water, and kept at −80°C. RNA yield and purity was determined spectrophotometrically at 260--280 nm and RNA integrity was verified by running samples on 1.5% agarose gels and staining with ethidium bromide.

2.3. Differential Display mRNA Analysis {#sec2.3}
---------------------------------------

The reverse transcription-PCR differential display (DDRT-PCR) analysis was performed as described \[[@B11]\] with minor modifications \[[@B12]\]. To yield starting material for the DDRT-PCR, total RNA preparations independently isolated from the LV and RV of three newborn piglets were, respectively, pooled at equal ratios, and 4 *μ*g of RNA was reverse transcribed using the SuperScript III (Invitrogen) and T7-oligo-dT primer. Pooled first-strand cDNAs were amplified side-by-side by PCR using 230 different primer combinations (10 two-base-anchored oligo-dT and 23 arbitrary primers purified by HPLC, [Table 1](#tab1){ref-type="table"}).

Nontemplate (NT) and non-RT RNA (N-RT) template reactions were used as negative controls. In each DDRT-PCR set-up, reactions were performed at least in duplicate to test whether differences in LV/RV gene expression are likely to be real. PCR was performed, using the AmpliTaq DNA polymerase (Invitrogen), under the following conditions: initial denaturation (94°C, 2 minutes), stage I (5 cycles, each of which included: 94°C, 30 seconds; 40°C, 1 minute; 72°C, 1 minute), stage II (25 cycles, each on which included: 94°C, 30 seconds; 50°C, 1 minute; 72°C, 1 minute), and final extension (72°C, 10 minutes), sample store at 6°C. PCR-amplified products were subjected to fractionation on 8% polyacrylamide gels (PAAG) (Mini-Protean-III, Bio-Rad) and fluorescently stained by SYBR Green I (Sigma). Image acquisition and intensity of bands were estimated by densitometry (VersaDoc 1000) and Quantity One software (Bio-Rad). Differentially regulated amplification products were defined as those bands that were similarly displayed at least in two experimental replicates. Using a sharp, sterile razor blade, a rectangular piece of gel corresponding to an individual band of interest on the PAAG was excised and electroeluted (D-tube Electroelution Kit, Novagen). After a short centrifugation, the eluate was transferred to a clean tube. The extracted DNA was used directly as the template for PCR with T7 and M13 reamplification primers (see [Table 1](#tab1){ref-type="table"}). Cycling conditions were as described for DDRT-PCR except stage I at 45°C and stage II (20 cycles) at 55°C. After reamplification, each PCR reaction was electrophoresed through a 1.5% agarose gel with ethidium bromide to assure that the correct sized fragment was amplified. Reamplified cDNA fragments were eluted (QIAquick Gel Extraction Kit, Qiagen), cloned into pCRII-TOPO vector (Invitrogen), and sequenced by (Secugen), (Madrid, Spain). The nucleotide sequences obtained were compared with known sequences by searching the GenBank database with BLAST algorithms.

2.4. Quantitative RT-PCR {#sec2.4}
------------------------

Differential gene expression was further confirmed by real-time quantitative PCR (qRT-PCR) as described \[[@B13]\] using Bio-Rad IQ5 instrument and Bio-Rad SYBR Green Mix \[[@B14], [@B15]\]. Whenever possible, the primer pairs were designed to be located in different exons of a given sequence. Individual heart-matched LV/RV cDNAs isolated from three newborn and three 20-day-old piglets were used as templates. Each primer pair used yielded a single peak of dissociation on the melting curve and a single band with expected size on PAAG \[[@B12]\]. A negative NT and N-RT controls were included in each reaction set. Detection of ribosomal protein L19 (RPL19) mRNA was used to normalize the expression of target mRNAs. The efficiency of target and reference amplification was tested and found to be approximately equal. Results were defined as the target genes expression normalized against *rpl19* gene expression in both ventricles. Fold changes were calculated using the C~T~ method. Primer sequences and additional details on qRT-PCR are available upon request.

2.5. Data Analysis {#sec2.5}
------------------

Values were expressed as means ± SEM. mRNA expression was quantified using the comparative threshold cycle method. Statistical analyses were performed with the SPSS 13 software. A *P* value \<.05 was considered to be statistically significant.

3. Results {#sec3}
==========

3.1. DDRT-PCR Analysis Allows Reliable Transcriptomic Profiling of Ventricular Myocardium in Newborn Piglets {#sec3.1}
------------------------------------------------------------------------------------------------------------

For mammalian cells, it was calculated that 20 arbitrary in conjunction with 12 anchored primers would statistically amplify all mRNA sequences \[[@B16]\]. We used 23 arbitrary and 10 two-base-oligo(dT) anchored primers ([Table 1](#tab1){ref-type="table"}), resulting in 230 display primer combinations. A total of about 5,600 distinct cDNA fragments corresponding to genes expressed in piglet LV/RV myocardium were detected. A representative example of DDRT-PCR banding patterns is illustrated in [Figure 2(a)](#fig2){ref-type="fig"}.

The average number of bands generated by one primer pair was 26, the minimum was 0, and the maximum was 44. About 70% of the primer pairs produced 20--40 bands ([Figure 2(b)](#fig2){ref-type="fig"}). Size distribution analysis of cDNA bands generated by DDRT-PCR revealed a minor fraction of short-sized (100--300 nt) bands, while the fragments with a size from 300 to 1,000 nt, which is a preferable choice for cloning and sequencing, made up about 60% of all detected bands ([Figure 2(c)](#fig2){ref-type="fig"}).

Taken together, the results indicated that under our experimental conditions, transcript-banding patterns generated by DDRT-PCR could be sufficient for comparative expression analysis of the LV versus RV myocardium of newborn piglets.

3.2. DDRT-PCR Profiling Identifies Differentially Expressed Genes in the LV versus RV Myocardium of Newborn Piglets {#sec3.2}
-------------------------------------------------------------------------------------------------------------------

Direct side-by-side comparison of the mRNAs between the LV and RV of the newborn piglet heart revealed that the majority of profiled genes (97%) were similarly expressed in both ventricles. Out of more than 5,600 DDRT-PCR bands amplified by the primer combinations used, a total of 153 bands, ranging in size from 300 to 1,000 nt, were identified as being qualitatively differentially displayed. Of these, 96 transcripts were enriched in the LV, whereas the remaining 57 were predominant in the RV.

[Figure 3](#fig3){ref-type="fig"}illustrates the relative differential expression of a representative set of bands in the LV as compared to the RV myocardium. Once differentially displayed PCR products were detected, the fragments which displayed over twofold LV-RV expression differences (40 bands) were recovered from gels, reamplified, cloned, and sequenced. The differential expression of these genes was further confirmed using qRT-PCR analysis. In this manner, over 80% (32 bands) of the selected bands were confirmed to be differentially expressed in the two ventricular chambers of newborn piglets ([Table 2](#tab2){ref-type="table"}).

The BLAST searches for sequence similarity revealed that 6 of the 32 cloned cDNA fragments with confirmed differential expression are potentially novel transcripts with no significant match in the current databases, suggesting that they may either encode as yet uncharacterized proteins or correspond to unknown regions of identified genes (untranslated, nonconserved regions). The remaining 26 cDNA sequences were identified by BLAST sequence comparisons as genes related to modulation of gene expression (PTPLAD1, PHB2, CEP290, JMJD1C), regulation of cell growth and differentiation (MSTN, MAP3K71P2, APOBEC3F, PHB2), biomechanical stress sensing and myofibrilar assembly (TTN, ANKRD1), muscle contraction (TNNT2, ACTC1), extracellular matrix remodeling (ADAMTS3, COL1A2), calcium control (SLC8A1), and energy metabolism (ATP5C1, ND6).

[Table 2](#tab2){ref-type="table"}provides details of the extent of relative LV/RV upregulation (fold change) as well as the known function(s) of identified genes. Among the differentially expressed genes, only a small portion displayed over 4-fold expression differences between LV and RV (PTPLAD1, TPM2, ACTC1, ANKRD1, ANKRD1-I8, PDE3A, D162, TNMD, D170). In this sense, chamber-dependent regulation of expression of these known and novel transcripts may be primarily associated with different patterns of postnatal ventricular remodeling.

MSTN (myostatin) characterized by LV-predominant expression in newborn myocardium also stood out as an interesting candidate, given its roles in cell growth and proliferation. Recently, it has been demonstrated that MSTN is a potent repressor of cardiac muscle cell proliferation and growth, and that in vivo loss of MSTN induces eccentric hypertrophy associated with enhanced responsiveness of ventricular myocytes to beta-adrenergic stimulation \[[@B17], [@B18]\]. We, therefore, examined this gene expression in both ventricles at advanced stages of postnatal development when morphological differences between concentric (LV) and eccentric (RV) remodeling become evident, that is in 20-day-old piglets (see [Figure 1(d)](#fig1){ref-type="fig"}). The LV/RV MSTN mRNA ratio found in newborn piglets (i.e., 2 : 1) was significantly amplified in 20-day-old animals (i.e., 6 : 1) due to MSTN upregulation in the LV of the latter age group, while the gene\'s expression levels in the RV were similar in two groups studied ([Figure 4](#fig4){ref-type="fig"}). The results indicate that in neonatal piglets a process of RV-eccentric remodeling is associated with the same relative low MSTN level as was found in the RV at birth.

Collectively, the comparison of gene expression between the LV and RV shortly after birth, when LV/RV loading conditions are dramatically changed as compared to the late-fetal period, demonstrates that such analysis provides clues for identifying hallmark genes whose expression is regulated in a chamber-dependent manner at the earliest stages of postnatal LV-concentric and RV-eccentric remodeling.

4. Discussion {#sec4}
=============

The DDRT-PCR technique, which was first developed in 1992 \[[@B19]\], is still the method of choice for an unbiased comparison of mRNA expression patterns between samples that are very similar and often results in identification of nonabundant, rare, or novel transcripts \[[@B10], [@B20], [@B21]\].

Using a nonradioactive DDRT-PCR technique, we identified the transcripts that reproducibly showed different expression levels between LV and RV in newborn piglets. These differences do not correlate with either cardiomyocyte cell volume \[[@B22]\] or ventricular wall thickness (\[[@B9]\]; see also [Figure 1(b)](#fig1){ref-type="fig"}, this work), which are practically equal in both piglet ventricles during or shortly after birth. Thus, in this system a molecular prepattern precedes the appearance of morphologically identifiable signs of LV-concentric and RV-eccentric hypertrophy. We suggest that the observed differences in gene expression are intrinsic to the distinct molecular makeup of the LV versus RV rather than to their hyperplastic/hypertrophic growth status, which is similar in both ventricles at birth. Further, the content of certain well-known markers of cardiomyocyte hypertrophy (beta-myosin heavy chain and myosin light chain 2 ventricular) was found to be similar in both the LV and RV of newborn piglets \[[@B9]\]. Moreover, expression levels of the transcriptional cofactor, myocardin, which induces cardiomyocyte hypertrophy \[[@B23], [@B24]\], are equal in both ventricles of these animals \[[@B25]\]. Therefore, it seems reasonable to interpret the differences in gene expression detected in our present work as indicative of an L--R molecular predisposition of the newborn myocardium to respond to dramatic changes of the hemodynamic loads shortly after birth when the LV is exposed to a higher-pressure load (concentric hypertrophy promoting condition) in comparison to the RV, which is exposed to a higher-volume load (eccentric hypertrophy promoting condition).

The vast majority of the transcripts differentially expressed in the LV and RV of newborn piglets correspond to genes which were not previously known to be asymmetrically expressed in the LV versus RV myocardium, excepting those coding for beta-spectrin \[[@B4]\], ANKRD1 \[[@B9]\], BNP \[[@B6], [@B9]\], calcium ATPase, matrix metalloproteinases, type 1 procollagens, and troponins \[[@B3]\]. In addition, other reports demonstrated that transcripts for proteins such as fibronectin, alpha-myosin heavy chain and transforming growth factor \[[@B26]\], and cytochrome c oxidase and heart isoforms of uncoupling proteins \[[@B27]\] are asymmetrically enriched in the LV versus RV mammalian myocardium.

Regulatory mechanisms resulting in LV/RV transcriptional differences in the newborn and early neonatal heart are largely unknown, but of special interest, because the functionally different roles of the two ventricles become apparent after birth. Our study characterizes the transcription status of the LV and RV at birth rather than the establishment of LV/RV transcription differences in the course of development \[[@B28]\]. In embryonic and fetal heart, expression of a number of transcription factors, including Hand1, Hand2, and Tbx5, shows LV/RV differences \[[@B29], [@B30]\]. We found \[[@B9]\] that Hand1 and Hand2 are equally expressed in both the LV and RV of newborn piglets, suggesting that these factors are not involved in maintaining L/R ventricular transcriptional differences after birth.

In this work, among the genes whose expression levels differentiate between the LV and RV, there is a small cohort of genes which could be involved in concentric versus eccentric hypertrophy signalling (see [Table 2](#tab2){ref-type="table"}). In this regard, several key regulators of muscle cell growth and proliferation (MAP3K7IP2, MSTN, PHB2, APOBEC3F) and gene expression (PTPLAD1, JMJD1C, CEP290) are differentially expressed between LV and RV piglet myocardium that may be relevant to intrinsic differences \[[@B31]\] that can regulate the chamber-dependent response of ventricular myocardium to workload. Interestingly, transition from "early" to "late" hypertension-induced hypertrophy in young adult rats is associated with predominant changes in expression of cell growth/proliferation and signal transduction factors \[[@B32]\].

Sequence analysis of the 32 cDNAs chosen based on differential LV/RV screening revealed a number of sequences, which may correspond to either previously uncharacterized genes or yet unidentified splice variants of the known cardioexpressed genes. In this sense, identification of the D36 fragment sequence (see [Table 2](#tab2){ref-type="table"}) as being completely identical to that located within intron 8 of the pig *ankrd1* gene led us to isolate and characterize three novel alternatively spliced *ankrd1* variants which are predominantly expressed in the LV of neonatal and adult pig and human hearts and markedly upregulated in the ventricular myocardium at experimental heart failure \[[@B12]\]. Similarly, the D170 fragment (see [Table 2](#tab2){ref-type="table"}), exhibiting homology with exon 1 and 3 sequences of the pig *nppb* gene, may represent a new form of alternative splicing of this cardioprotective factor.

Various cardiac disease states can result in an imbalance of chamber-associated expression patterns in ventricular myocardium. In the rat infarct model, a shift in chamber-dependent gene expression towards relative downregulation of gene expression in the RV as compared to the LV has been reported \[[@B3]\]. In the porcine model of cardiotoxic cardiomyopathy we have demonstrated that the normal asymmetric LV/RV pattern of ANKRD1 mRNA and protein distribution was completely abolished at end-stage heart failure; improvement of cardiac performance resulted in the restoration of this gene\'s LV/RV asymmetric expression \[[@B9]\]. In the pig model of volume overload (eccentric hypertrophy promoting condition), angiotensinogen and prepro-endothelin expression levels were significantly upregulated in the RV while remaining uncharged in the LV \[[@B31]\]. In the mouse model of RV pressure-overload hypertrophy, over 10 transcripts showed significant upregulation in the afterload stressed RV, but not in the afterload stressed LV, including three genes from the Wnt signaling pathway, and genes involved in apoptosis \[[@B33]\]. In young rats, chronic hypoxia resulted in a shift from an LV- to an RV-predominant pattern in cytochrome c oxidase expression \[[@B27]\].

In sum, although not all of the identified genes with differential LV/RV expression have a clearly defined cardiac-related function(s) at this time, the results of our work do advance the understanding of the complex mechanisms that could be involved in concentric versus eccentric remodeling of ventricular myocardium under normal conditions. More broadly, the identification of specific expression signatures of concentric versus eccentric hypertrophy may be useful in the elucidation of molecular pathways involved not only in physiological but also in pathological myocardial remodelling and heart failure.

5. Conclusions {#sec5}
==============

Using an unbiased DDRT-PCR analysis, we were able to identify a set of genes with divergent LV versus RV expression. To our knowledge, this is the first study to account for large-scale gene expression profiling in early neonatal myocardium in mammals which revealed a certain molecular predisposition of the LV and RV, respectively, to concentric or eccentric hypertrophic remodeling. The reliability of these findings is supported by confirmation of the results by qRT-PCR and recognition of a fraction of the differentially expressed genes as known genes involved in pathological ventricular remodeling and heart failure. In addition, our data demonstrate chamber-dependent alterations in the expression of as yet uncharacterised novel genes that may be associated with different patterns of ventricular hypertrophic remodeling and can be used to study a board range of heart disease phenotypes.

HPLC-purified primers for DDRT-PCR were a generous gift from Dr. Max Rothschild (Iowa State University, USA). This work was partially supported by Grants (SAF2004-01462 and SAF2008-00337) from the Spanish Ministry of Science and Innovation and by a Grant (08CSA008161PR) from the Autonomic Government of Galicia.

![Heart dimensions (a and b) and left/right ventricular cross-sections (c and d) of newborn and 20-day-old piglets. LV/RV---left/right ventricle. (a), (b) Levels of cross sections are shown by dotted lines. (c), (d) Boundaries of the LV/RV free wall are marked by white arrows.](JBB2010-603159.001){#fig1}

![Differential display (DDRT-PCR) analysis of gene expression in left/right ventricles (LV/RV) of newborn piglets. (a) Representative gel images of DDRT-PCR bands amplified with three distinct sets of primer combinations (H07-A09, H08-A19, and H09-A19), showing highly reproducible band patterns in each replicate. Nondenaturing 8% PAAG poststained with SYBR Green I. 200--2500 bp---DNA size standards (GeneRuler DNA ladder mix, Fermentas). (b and c) Number and size distribution frequencies of bands generated by DDRT-PCR.](JBB2010-603159.002){#fig2}

![Examples of the bands, displaying over twofold LV versus RV expression differences in newborn piglets. The primer pairs used for DDRT-PCR amplifications are shown. Nondenaturing 8% PAAG poststained with SYBR Green I. LV/RV: left/right ventricle. 200--2500 bp: DNA size standards (GeneRuler DNA ladder mix, Fermentas). Arrows: the bands (D106, D137, D123, and D132), which correspond to the transcripts differentially displayed between LV and RV. For further details see [Table 2](#tab2){ref-type="table"}.](JBB2010-603159.003){#fig3}

![Estimation of myostatin (MSTN) mRNA levels in the LV and RV of newborn and 20-day-old piglets. (a) Representative qPCR amplification plot of MSTN mRNA levels in the LV (red) and RV (blue) of three 20-day-old piglet hearts. Internal RPL19 reference levels in the LV (red) and RV (blue) are shown. Arrows: threshold cycle (C~T~). FT: fluorescent threshold. ΔC~*T*~: differences in threshold cycles for target and reference. NTC: nontemplate controls. B: MSTN mRNA levels in the LV versus RV ventricle of newborn and 20-day-old piglets. \**P* \< .05, newborn piglets (*n* = 3). ^\#^*P* \< .05, 20-day-old piglets (*n* = 3).](JBB2010-603159.004){#fig4}

###### 

Primers used in differential display RT-PCR analysis.

  T7-Oligo(dT)                                     
  ------------------------------------------------ -------------------------------------
  two-base anchored oligo-dT antisense primers\*   
  H01                                              **ACGACTCACTATAGGGC**TTTTTTTTTTTTGA
  H02                                              ACGACTCACTATAGGGCTTTTTTTTTTTTGC
  H03                                              ACGACTCACTATAGGGCTTTTTTTTTTTTGG
  H04                                              ACGACTCACTATAGGGCTTTTTTTTTTTTGT
  H05                                              ACGACTCACTATAGGGCTTTTTTTTTTTTCA
  H06                                              ACGACTCACTATAGGGCTTTTTTTTTTTTCC
  H07                                              ACGACTCACTATAGGGCTTTTTTTTTTTTCG
  H08                                              ACGACTCACTATAGGGCTTTTTTTTTTTTAA
  H09                                              ACGACTCACTATAGGGCTTTTTTTTTTTTAC
  H10                                              ACGACTCACTATAGGGCTTTTTTTTTTTTAG
                                                   
  10-mer arbitrary sense primers\*\*               
  A01                                              **ACAATTTCACACAGGA**CGACTCCAAG
  A02                                              ACAATTTCACACAGGAGCTAGCATGG
  A03                                              ACAATTTCACACAGGAGACCATTGCA
  A04                                              ACAATTTCACACAGGAGCTAGCAGAC
  A05                                              ACAATTTCACACAGGAATGGTCGTCT
  A06                                              ACAATTTCACACAGGATACAACGAGG
  A07                                              ACAATTTCACACAGGATGGATTGGTC
  A08                                              ACAATTTCACACAGGATGGTAAAGGG
  A09                                              ACAATTTCACACAGGATAAGCCTAGC
  A10                                              ACAATTTCACACAGGAGATCTCAGAC
  A11                                              ACAATTTCACACAGGAACGCTAGTGT
  A12                                              ACAATTTCACACAGGAGGTACTAAGG
  A13                                              ACAATTTCACACAGGAGTTGCACCAT
  A14                                              ACAATTTCACACAGGATCCATGACTC
  A15                                              ACAATTTCACACAGGACTTTCTACCC
  A16                                              ACAATTTCACACAGGATCGGTCATAG
  A17                                              ACAATTTCACACAGGACTGCTAGGTA
  A18                                              ACAATTTCACACAGGATGATGCTACC
  A19                                              ACAATTTCACACAGGATTTTGGCTCC
  A20                                              ACAATTTCACACAGGATCGATACAGG
  A21                                              ACAATTTCACACAGGACAGGCAGCAG
  A23                                              ACAATTTCACACAGGATATGGCGCCG
  A24                                              ACAATTTCACACAGGAGCTGAACCGG
                                                   
  primers for reamplification of DD bands          
  T7                                               GTAATACGACTCACTATAGGGC
  M13rev-48p                                       AGCGGATAACAATTTCACACAGGA

\*Each anchor primer has T7 sequence (bold) on the 5′ end.

\*\*Each arbitrary primer has M13 sequence (bold) on the 5′ end.

###### 

Analysis of the transcripts identified by DDRT-PCR as upregulated in the LV/RV of newborn piglets.

                                             Gene identification                                            
  ------- ---- ------ --------- ------------ --------------------- -------------- ------ ------------------ ----------------------------------------------
  D005    LV   250    H01-A05   2.1 ± 0.3    *TTN*                 AJ560658       98%    *S. Scrofa*        myofibrillar stretch-sensor system,
  D015    LV   500    H03-A04   1.7 ± 0.2    *MAP3K7IP2*           NM_015093      94%    *H. sapiens*       proliferation and anti-apoptotic signalling
  D024    LV   275    H04-A01   1.5 ± 0.2    *TNNT2*               AY277394       71%    *H. sapiens*       regulation of muscle contraction
  D034    LV   450    H06-A03   2.1 ± 0.3    *ATP5C1*              NM_005174      86%    *H. sapiens*       ATP synthesis
  D036    LV   400    H06-A04   4.2 ± 0.3    *ANKRD1-i8*           FJ475066       100%   *S. scrofa*        ANKRD1 splice isoform
  D046    LV   400    H08-A01   2.0 ± 0.3    *ADAMTS3*             BC132735       88%    *H. sapiens*       extracellular matrix degrading enzyme
  D106    LV   450    H08-A07   2.2 ± 0.4    *Unknown*             ---            ---    ---                ---
  D123    LV   1400   H06-A10   4.2 ± 0.2    *PTPLAD1*             NM_001103316   90%    *B. taurus*        modulation of gene expression
  D128A   LV   900    H05-A14   2.3 ± 0.2    *SLC8A1*              NM_001112802   87%    *H. sapiens*       calcium level control
  D128B   LV   900    H05-A14   3.2 ± 0.5    *CTSH*                EU532429       79%    *S. scrofa*        degradation of proteins in lysosomes
  D130    LV   800    H06-A14   4.2 ± 0.4    *PDE3A*               XM_520783      77%    *P. troglodytes*   hydrolysis of cyclic nucleotides
  D132    LV   310    H08-A15   5.6 ± 0.4    *TPM2*                NG_011620      80%    *H. sapiens*       regulation of muscle contraction
  D133    LV   350    H10-A13   2.1 ± 0.4    *SERPINB9*            NM_004155      73%    *H. sapiens*       inactivation of serine proteinases
  D134    LV   200    H08-A18   2.6 ± 0.4    *ND6*                 AY063320       96%    *H. sapiens*       ATP production
  D137    LV   415    H04-A18   2.6 ± 0.4    *MSTN*                AY208121       95%    *S. scrofa*        negative regulator of muscle growth
  D144    LV   180    H03-A18   4.0 ± 0.2    *ACTC1*               FM212567       83%    *S. scrofa*        contractile apparatus assembling
  D147    LV   500    H02-A07   3.7 ± 0.3    *INHBA*               NM_214028      86%    *S. scrofa*        myocardial remodelling and tissue repair
  D151A   LV   435    H05-A07   2.1 ± 0.3    *Unknown*             ---            ---                       ---
  D151B   LV   435    H05-A07   1.6 ± 0.2    *COL1A2*              NG_007405      77%    *H. sapiens*       formation of fibrillar collagen
  D153    LV   300    H05-A02   1.6 ± 0.3    *PHB2*                NM_001046198   80%    *B. taurus*        transcriptional repression regulation
  D155    LV   930    H10-A23   9.2 ± 0.3    *ANKRD1*              NM_213922      100%   *S. scrofa*        myofibrillar stretch-sensor system
  D162    LV   930    H05-A23   4.1 ± 0.5    *Unknown*             ---            ---    ---                ---
  D165    LV   1000   H03-A24   2.1 ± 0.4    *Unknown*             ---            ---    ---                ---
  D170    LV   360    H06-A21   10.8 ± 0.7   *NPPB*                NM_213846      100%   *S. scrofa*        new NPPB putative splice isoform\*\*
  D006    RV   600    H01-A05   2.5 ± 0.4    *Unknown*             ---            ---    ---                ---
  D42B    RV   600    H07-A01   3.1 ± 0.2    *CEP290*              NM_025114      89%    *H. sapiens*       transcription activation (via ATF-4 factor)
  D050    RV   450    H08-A04   2.0 ± 0.5    *SPTBN1*              AB371586       92%    *H. sapiens*       determination of cell shape
  D051    RV   400    H08-A05   1.9 ± 0.2    *SLC41A1*             NM_173854      78%    *H. sapiens*       magnesium transporter
  D103    RV   350    H06-A12   5.5 ± 0.2    *TNMD*                XM_001088536   69%    *M. mulatta*       angiogenesis inhibitor
  D104    RV   900    H06-A07   2.1 ± 0.3    *APOBEC3F*            FJ042939       83%    *S. scrofa*        growth and cell cycle control
  D145    RV   375    H08-A19   3.3 ± 0.4    *Unknown*             ---            ---    ---                ---
  D146    RV   850    H05-A13   1.9 ± 0.2    *JMJD1C*              NM_032776      91%    *H. sapiens*       hormone-dependent transcriptional activation

\*Fold change determined by qPCR. \*\*The D170 band sequence exhibits homology with exon 1 and 3 sequences of the pig *nppb* gene.

*ACTC1*: actin, alpha, cardiac muscle 1; *ADAMTS3*: ADAM metallopeptidase with thrombospondin type 1 motif 3; *ANKRD1*: ankyrin repeat domain 1 (cardiac muscle); *ANKRD1-i8*: *ANKRD1* retaining intron 8; *APOBEC3F*: apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F; *ATP5C1*: ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1; *CEP290*: centrosomal protein 290 kDa; *COL1A2*: collagen, type I, alpha 2; *CTSH*: cathepsin H; *INHBA*: inhibin, beta A; *JMJD1C*: jumonji domain containing 1C; *MAP3K7IP2*: mitogen-activated protein kinase kinase kinase 7 interacting protein 2; *MSTN*: myostatin; *ND6*: mitochondrially encoded NADH dehydrogenase 6; *NPPB*: natriuretic peptide precursor B; *PDE3A*: phosphodiesterase 3A, cGMP-inhibited; *PHB2*: prohibitin 2; *PTPLAD1*: protein tyrosine phosphatase-like A domain containing 1; *SERPINB9*: serpin peptidase inhibitor, clade B (ovalbumin), member 9; *SLC41A1*: solute carrier family 41, member 1; *SLC8A1*: solute carrier family 8 (sodium/calcium exchanger), member 1; *SPTBN1*: spectrin, beta, non-erythrocytic 1; *TNMD*: tenomodulin; *TNNT2*: troponin T type 2 (cardiac); *TPM2*: tropomyosin 2 (beta); *TTN*: titin.
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